The Food and Drug Administration has approved the first at-home, vaginal-sample self-collection device for cervical cancer screening, according to a press release from the device manufacturer, Teal Health. As an alternative to in-office sampling and screening, the home collection method also includes virtual access to providers who prescribe the sample-collection kit, review the results from the lab, and answer patient questions. After the patient receives the at-home kit and collects the samples using a wand …
Read More